Respiratory Test Kit DASH® SARS-CoV-2 & Flu A + B 20 Tests CLIA Waived

Features

• The DASH SARS-CoV-2 & Flu A/B Test is a rapid reverse transcription polymerase chain reaction (RT-PCR) assay performed on the DASH Rapid PCR Instrument and is intended for the simultaneous in vitro qualitative detection and differentiation of SARS-CoV-2, influenza A and inflenza B virus ribonucleic acid (RNA) in anterior nasal swab specimens from patients with signs and symptoms of respiratory tract infection
• The test is intended to aid in the differential diagnosis of SARS-CoV-2, influenza A, and influenza B in humans in conjunction with other clinical, epidemiologic and laboratory findings
• Positive results of a specific target are indicative of the presence of that viral RNA and may not be the definite cause of disease
• Positive results do not rule out co-infection with other pathogens. Negative results do not preclude SARS-CoV-2, influenza A or influenza B infection and should not be used as the sole basis for patient management decisions
• Anterior nasal swab sample collection rather than more invasive nasopharyngeal swabs